Is there a role for stenting in case of acute esophageal variceal bleeding?

Pharmacological therapy with endoscopic band ligation (EBL) fails in 10 to 20% of patients to control acute bleeding caused by rupture of esophageal varices [1]. Initial failure to control bleeding or early rebleeding has a significant impact on mortality. To reduce the incidence of treatment failure and death, more aggressive therapies may be used in patients with high risk of treatment failure. Rescue therapy is indicated when endoscopic treatment combinedwith pharmacological therapy has failed to control bleeding. In this situation, there are three possibilities: (1) the balloon tamponade (BT); (2) the insertion of a transjugular intrahepatic portosystemic shunt (TIPS); and (3) the insertion of an esophageal covered self-expanding metal stent (SEMS). The conclusions of the Baveno V consensus workshop published in 2010 concerning management of treatment failures are: (1) BT should only be used in massive bleeding as a temporary “bridge” until definitive treatment can be instituted (for a maximum of 24h, preferably in an intensive care facility); (2) persistent bleeding despite combined pharmacological and endoscopic therapy is best managed by TIPS with covered stents; (3) rebleeding during the first 5 days may be managed by a second attempt at endoscopic therapy; however, if rebleeding is severe, TIPS with covered stents is likely to be the best option; and (4) uncontrolled data suggest that SEMS may be an option in refractory esophageal bleeding, although further evaluation is needed [2]. Since this workshop, there have been no new data concerning BT, an old procedure with several disadvantages: need of skilled personnel, high incidence of serious complications, success rate in achieving short-term hemostasis between 50 to 90%, frequent rebleeding on removal of the tube [3]. Concerning this point, nothing has changed and BT remains only a holdingmeasure until a definitive procedure can be performed. Conversely, interesting data concerning SEMS in this emergency context have been published. In this issue of EIO, Kinesh et al. publish an exhaustive review evaluating the technical feasibility, efficacy, and safety of SEMS as a rescue for acute variceal bleeding among 108 patients (91 males, 17 females). Mean age calculated from all reported cases was 54.3, as expected for cirrhotic patients. Of the patients 48 were reported to have Child-Pugh score class C and 32 were class B. In most studies collected by Kinesh et al., SEMS is a nitinol, removable, covered-by-polyurethanefoil, self-expanding metal stent. The stent placement (with a guidewire) and the removal (with retrieval loops) could be easily done endoscopically without radiological guidance, making it a more practical therapeutic intervention to stabilize a bleeding patient. SEMSwas successfully deployed in 100 out of 108 cases; immediate hemostasis was obtained among 96 patients, and rebleeding occurred with only 4 patients. Stents remain safely intact for 4 to 14 days in most cases. Successful SEMS extraction was performed in almost all cases under endoscopic guidance without any reported technical difficulty. Stent migration, which was the most common complication, was observed in 21% of the patients but not associated with rebleeding. Unfortunately, a total of 27 patients (25%) died within 7 to 60 days, mostly due to progressive hepatic decompensation and/ or multiorgan failure. These results must be compared with those of TIPS.Acute variceal bleeding that is poorly controlled with endoscopic therapy is generally well controlled with TIPS, which has a success rate of 90 to 100%. However, TIPS has a mortality rate of 27 to 50% [4]. As with SEMS, death occurring within 30 days of the procedure is most commonly caused by multiorgan failure, and death more than 30 days following the procedure is most commonly related to liver failure. Increased mortality is related to a Child-Pugh class C clinical sta-